Willem van Schaik
Microbiology, microbiome, antimicrobial resistance. Sometimes UK politics. Head of Research of the School of Infection, Inflammation and Immunology, University of Birmingham. Also Co-Director of @target-amr.bsky.social.
- Sir Paul Nurse PRS writes in today's Times on cuts to UKRI funding: "If [discovery-driven science] is not properly supported, we lose the seed-corn of discovery research, harming subsequent science translation, societal improvement and economic growth." Read more(£): www.thetimes.com/comment/lett...
- 'You may be aware of recent pauses to some programmes. For our curiosity-driven research [CDR] (...) headroom in funding will increase (...) and you can expect to see new opportunities opening later this year (...) Levels of funding for [CDR] will remain stable (...) are reflective of recent years'
- Today, we're sharing an open letter from our Chief Executive, Professor Sir Ian Chapman, outlining changes to UKRI investment approach, and addressing concerns about research funding and the financial position of STFC. Read his letter here: www.ukri.org/news/open-le...
